Other Specialty Retail

Bark

Bark released FY2026 Q2 earnings on November 10 Pre-Market (EST), actual revenue USD 106.97 M (forecast USD 103.57 M), actual EPS USD -0.0624 (forecast USD -0.03)

Bark released FY2026 Semi-Annual earnings on November 10 Pre-Market (EST), actual revenue USD 209.83 M, actual EPS USD -0.1041

Bark Inc. Reports Q2 Revenue Above Guidance but Net Loss Increases

Bark to Release FY2026 Q2 Earnings on November 10, Pre-Market EST; Forecast Revenue USD 103.57M, EPS USD -0.03

Bark released FY2026 Q1 earnings on August 7 Pre-Market (EST), actual revenue USD 102.86 M (forecast USD 99.63 M), actual EPS USD -0.0413 (forecast USD -0.03)

Bark to Release FY2026 Q1 Earnings on August 7, 2025, Pre-Market EST; Forecast Revenue USD 99.63 M, EPS USD -0.03

Bark Inc. to Release Q1 2026 Financial Report

Bark Receives Second Non-Compliance Warning from NYSE and Explores Compliance Solutions

Bark Inc. Considers Reverse Stock Split to Meet NYSE Listing Requirements

Bark Inc's Executive Chairman Matt Meeker Acquires Common Stock

Jefferies Downgrades BARK Price Target

BARK, Inc. Reports First Positive Annual Adjusted EBITDA

Bark released FY2025 earnings on June 4 After-Market EST, actual revenue USD 484.18 M (forecast USD 495.58 M), actual EPS USD -0.1885 (forecast USD -0.16)

Bark released FY2025 Q4 earnings on June 4 After-Market EST, actual revenue USD 115.41 M (forecast USD 126.74 M), actual EPS USD -0.0349 (forecast USD -0.02)

BARK Reports EPS in Line with Estimates, Stock Price Rises

BARK Reports Q4 2025 Earnings with Net Loss of $6.1 Million

BARK Inc. Expected Q4 Earnings Report

Bark to Release FY2025 Q4 Earnings on June 4 After-Market EST, Forecast Revenue USD 126.74 M, EPS USD -0.02

Bark released FY2025 Q3 earnings on February 5 After-Market (EST), actual revenue $126.45M (forecast $126.31M), actual EPS -$0.0655 (forecast -$0.06)

Bark released FY2025 9 Months Earnings on February 5 After-Market (EST), with actual revenue of 368.77 M USD and actual EPS of -0.1527 USD

Mega Fortune

Processa Pharmaceuticals

cbdMD

Agape ATP

VYNE Therapeutics

Andersen

Inspirato

Medline Inc.

Creative Global Tech

GCI LIBERTY INC COM USD0.01 SER C SUBS RTS 17/12/2025

Envela

Tractor Supply

Ulta Beauty

Dick's Sporting Goods

Chewy

Five Below

Warby Parker

Sally Beauty

Upbound

Build A Bear

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap